Mark Strobeck Windtree Therapeutics Inc (WINT) insider trading activity

WINT Quotes by TradingView

Mark Strobeck is Director of WINDTREE THERAPEUTICS INC . Currently has a direct ownership of 2,300 shares of WINT, which is worth approximately $7,314. The most recent transaction as insider was on Aug 23, 2023, when has been sold 2,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.3K
0% 3M change
n/a 12M change
Total Value Held $7,314

Mark Strobeck Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 23 2023
BUY
Grant, award, or other acquisition
-
2,300 Added 50.0%
2,300 Common Stock

Also insider at

RMTI
ROCKWELL MEDICAL, INC. Healthcare
President and CEO
MS

Mark Strobeck

Director
Wixom, MI

Track Institutional and Insider Activities on WINT

Follow WINDTREE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WINT shares.

Notify only if

Insider Trading

Get notified when an Windtree Therapeutics Inc insider buys or sells WINT shares.

Notify only if

News

Receive news related to WINDTREE THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on WINT